Tirzepatide
Tirzepatide is a synthetic peptide-based medication developed for metabolic disorders, primarily type 2 diabetes and obesity. It acts as a dual agonist, targeting both the GIP and GLP-1 receptors to improve blood sugar control, reduce appetite, and support weight loss.
99% Purity Verified
This product is currently unavailable.
About Tirzepatide
Synthetic peptide-based medication designed for metabolic and endocrine research and therapeutic use Dual GIP and GLP-1 receptor agonist that influences insulin secretion, appetite regulation, and glucose control Used clinically and in studies focused on type 2 diabetes management and weight reduction
Specifications
Molecular Weight4,819 g/mol
Purity99%
SequenceY-Aib-Q-G-A-G-T-F-T-S-D-Y-S-I-L-A-A-A-K-A-F-I-E-W-L-E-G-N-N-Y-NH2